Literature DB >> 4698526

Ultrastructure of a composite glioma-sarcoma of the brain.

C E Peña, R Felter.   

Abstract

Entities:  

Mesh:

Year:  1973        PMID: 4698526     DOI: 10.1007/bf00689008

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  15 in total

1.  SOFT TISSUE SARCOMAS: ELECTRON MICROSCOPIC APPROACH TO HISTOGENETIC CLASSIFICATION.

Authors:  V A STEMBRIDGE; F J LUIBEL; C T ASHWORTH
Journal:  South Med J       Date:  1964-07       Impact factor: 0.954

2.  ELECTRON MICROSCOPIC OBSERVATIONS ON ASTROCYTOMAS.

Authors:  D DUFFELL; L FARBER; S CHOU; J F HARTMANN; E NELSON
Journal:  Am J Pathol       Date:  1963-10       Impact factor: 4.307

3.  Sarcoma arising in glioblastoma of the brain.

Authors:  I H FEIGIN; S W GROSS
Journal:  Am J Pathol       Date:  1955 Jul-Aug       Impact factor: 4.307

4.  The endothelial hyperplasia of the cerebral blood vessels with brain tumors, and its sarcomatous transformation.

Authors:  I FEIGIN; L B ALLEN; L LIPKIN; S W GROSS
Journal:  Cancer       Date:  1958 Mar-Apr       Impact factor: 6.860

5.  The development of contiguous sarcomatous and gliomatous tissue in intracranial tumours.

Authors:  L J RUBINSTEIN
Journal:  J Pathol Bacteriol       Date:  1956-04

6.  Astroblastoma and perithelial sarcoma in a case of neoplastic disease of the brain.

Authors:  J D FRENCH
Journal:  J Neuropathol Exp Neurol       Date:  1949-04       Impact factor: 3.685

7.  Human brain tumors: an electron-microscopic study.

Authors:  A J RAIMONDI; S MULLAN; J P EVANS
Journal:  J Neurosurg       Date:  1962-09       Impact factor: 5.115

8.  The development of sarcomas from transplants of the hyperplastic stromal endothelium of glioblastoma multiforme.

Authors:  H S Greene; E K Harvey
Journal:  Am J Pathol       Date:  1968-09       Impact factor: 4.307

9.  Contiguous glioblastoma multiforme and fibrosarcoma with extracranial metastasis.

Authors:  D R Smith; J M Hardman; K M Earle
Journal:  Cancer       Date:  1969-08       Impact factor: 6.860

10.  Nuclear inclusions in malignant gliomas.

Authors:  D M Robertson; J D MacLean
Journal:  Arch Neurol       Date:  1965-09
View more
  9 in total

1.  Contribution of histiocytic cells to sarcomatous development of the gliosarcoma. An immunohistochemical study.

Authors:  N Kochi; H Budka
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

2.  Histogenesis of sarcomatous component of the gliosarcoma: an ultrastructural study.

Authors:  K L Ho
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  Gliosarcoma: an immunohistochemical study.

Authors:  J W Grant; P V Steart; A Aguzzi; D B Jones; P J Gallagher
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Gliosarcomas: histological, immunohistochemical, ultrastructural, and tissue culture studies.

Authors:  F Slowik; K Jellinger; L Gaszó; J Fischer
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

5.  GFAP, F VIII/RAg, laminin, and fibronectin in gliosarcomas: an immunohistochemical study.

Authors:  D Schiffer; M T Giordana; A Mauro; A Migheli
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

Review 6.  Gliofibromas (including malignant forms), and gliosarcomas: a comparative study and review of the literature.

Authors:  M Cerda-Nicolas; J J Kepes
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  Cerebral gliosarcoma: prognostic factors.

Authors:  L Cervoni; P Celli
Journal:  Neurosurg Rev       Date:  1996       Impact factor: 3.042

8.  Sarcomatous proliferation of the vasculature in a subependymoma.

Authors:  D N Louis; E T Hedley-Whyte; R L Martuza
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

9.  Interrelationship between differentiation and malignancy-associated properties in glioma.

Authors:  M C Frame; R I Freshney; P F Vaughan; D I Graham; R Shaw
Journal:  Br J Cancer       Date:  1984-03       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.